UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

P43 Hepatic Encephalopathy Following TIPS Placement: The Impact of New VIATORR Controlled Expansion (VCX) Stents in a Real-Life Experience

The American journal of gastroenterology, 2023-09, Vol.118 (9S), p.S29-S30

2023

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Transjugular Intrahepatic Portosystemic Shunt on Nutrition in Liver Cirrhosis Patients: A Systematic Review

Nutrients, 2023-03, Vol.15 (7), p.1617

2023

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and impact of sarcopenia in non‐cirrhotic portal hypertension

Liver international, 2019-10, Vol.39 (10), p.1937-1942

2019

Link zum Volltext

Verfügbarkeit prüfen

Colonic Epithelial Permeability to Ions Is Restored after Vedolizumab Treatment and May Predict Clinical Response in Inflammatory Bowel Disease Patients

International journal of molecular sciences, 2024-06, Vol.25 (11), p.5817

2024

Link zum Volltext

Verfügbarkeit prüfen

The Effects of 12-Week Beta-Hydroxy-Beta-Methylbutyrate Supplementation in Patients with Liver Cirrhosis: Results from a Randomized Controlled Single-Blind Pilot Study

Nutrients, 2021-07, Vol.13 (7), p.2296

2021

Link zum Volltext

Verfügbarkeit prüfen

Diabetes and Metabolic Disorders: Their Impact on Cardiovascular Events in Liver Transplant Patients

Canadian journal of gastroenterology & hepatology, 2023, Vol.2023, p.1-9

2023

Link zum Volltext

Verfügbarkeit prüfen

Ammonia and the Muscle: An Emerging Point of View on Hepatic Encephalopathy

Journal of clinical medicine, 2022-01, Vol.11 (3), p.611

2022

Link zum Volltext

Verfügbarkeit prüfen

Infection prevention and control programme and COVID-19 measures: Effects on hospital-acquired infections in patients with cirrhosis

JHEP reports, 2023-05, Vol.5 (5), p.100703-100703, Article 100703

2023

Link zum Volltext

Verfügbarkeit prüfen

Role of Transjugular Intrahepatic Portosystemic Shunt in the Liver Transplant Setting

Journal of clinical medicine, 2024-01, Vol.13 (2), p.600

2024

Link zum Volltext

Verfügbarkeit prüfen

Reply to: “Reevaluating myosteatosis criteria in cirrhosis: Fluid and gender considerations”

Journal of hepatology, 2024-07

2024

Link zum Volltext

Verfügbarkeit prüfen

A Graphical Tool for Model-Driven Development Using Components and Services

2015 41st Euromicro Conference on Software Engineering and Advanced Applications, 2015, p.181-182

2015

Link zum Volltext
IEEE_Xplore

A Heterogeneous Approach for Developing Applications with FIWARE GEs

Service Oriented and Cloud Computing, p.65-79

Link zum Volltext

Verfügbarkeit prüfen

Emerging drugs for the treatment of sarcopenia in cirrhosis of the liver

Expert opinion on emerging drugs, 2024-04, Vol.29 (2), p.1-91

2024

Link zum Volltext

Verfügbarkeit prüfen

Albumin levels are associated with portal hypertension in patients with porto sinusoidal vascular disorder

Journal of hepatology, 2023-06, Vol.78, p.S950

2023

Link zum Volltext

Verfügbarkeit prüfen

THU-261 - Albumin levels are associated with portal hypertension in patients with porto sinusoidal vascular disorder

Journal of hepatology, 2023-06, Vol.78, p.S950-S950

2023

Link zum Volltext

Verfügbarkeit prüfen

WED-022 De novo malignancies after liver transplantation: a twenty years long-single center experience

Journal of hepatology, 2024-06, Vol.80, p.S364-S364

2024

Link zum Volltext

Verfügbarkeit prüfen

Role of extracellular vesicles in sarcopenia associated to chronic liver diseases

Journal of hepatology, 2023-06, Vol.78, p.S218-S219

2023

Link zum Volltext

Verfügbarkeit prüfen

THU-352 - Role of extracellular vesicles in sarcopenia associated to chronic liver diseases

Journal of hepatology, 2023-06, Vol.78, p.S218-S219

2023

Link zum Volltext

Verfügbarkeit prüfen

SAT083 - Preliminary results of the effects of beta-hydroxy-beta-methylbutyrate supplementation in patients with liver cirrhosis: a randomized controlled pilot study

Journal of hepatology, 2020-08, Vol.73, p.S690-S690

2020

Link zum Volltext

Verfügbarkeit prüfen

Preliminary results of the effects of beta-hydroxy-beta-methylbutyrate supplementation in patients with liver cirrhosis: a randomized controlled pilot study

Journal of hepatology, 2020-08, Vol.73, p.S690

2020

Link zum Volltext

Verfügbarkeit prüfen

THU-350 - Platelets from patients with decompensated cirrhosis display pro-inflammatory features

Journal of hepatology, 2023-06, Vol.78, p.S217-S218

2023

Link zum Volltext

Verfügbarkeit prüfen

Platelets from patients with decompensated cirrhosis display pro-inflammatory features

Journal of hepatology, 2023-06, Vol.78, p.S217-S218

2023

Link zum Volltext

Verfügbarkeit prüfen

The additive value of sarcopenia, myosteatosis and hepatic encephalopathy in the predictivity of model for end-stage liver disease

Digestive and liver disease, 2019-11, Vol.51 (11), p.1508-1512

2019

Link zum Volltext

Verfügbarkeit prüfen

FRI-398-Impact of sarcopenia and myosteatosis on post-transplant complications and survival

Journal of hepatology, 2019-04, Vol.70 (1), p.e570-e570

2019

Link zum Volltext

Verfügbarkeit prüfen

Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis

Journal of hepatology, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(33)

Publikationsform

Sprache

Englisch
(37)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(15)
Liver Cirrhosis
(8)
Sarcopenia
(7)
Humans
(6)
Hypertension
(6)
Cirrhosis
(5)
Gastroenterology & Hepatology
(5)
Liver Diseases
(5)
Mortality
(5)
Patients
(5)
Ascites
(4)
Care And Treatment
(4)
Computer Science
(4)
Computer Science, Software Engineering
(4)
Hepatic Encephalopathy
(4)
Technology
(4)
Component Model
(3)
General & Internal Medicine
(3)
Liver
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

P43 Hepatic Encephalopathy Following TIPS Placement: The Impact of New VIATORR Controlled Expansion (VCX) Stents in a Real-Life Experience

The Impact of Transjugular Intrahepatic Portosystemic Shunt on Nutrition in Liver Cirrhosis Patients: A Systematic Review

Prevalence and impact of sarcopenia in non‐cirrhotic portal hypertension

Colonic Epithelial Permeability to Ions Is Restored after Vedolizumab Treatment and May Predict Clinical Response in Inflammatory Bowel Disease Patients

The Effects of 12-Week Beta-Hydroxy-Beta-Methylbutyrate Supplementation in Patients with Liver Cirrhosis: Results from a Randomized Controlled Single-Blind Pilot Study

Diabetes and Metabolic Disorders: Their Impact on Cardiovascular Events in Liver Transplant Patients

Ammonia and the Muscle: An Emerging Point of View on Hepatic Encephalopathy

Infection prevention and control programme and COVID-19 measures: Effects on hospital-acquired infections in patients with cirrhosis

Role of Transjugular Intrahepatic Portosystemic Shunt in the Liver Transplant Setting

Reply to: “Reevaluating myosteatosis criteria in cirrhosis: Fluid and gender considerations”

A Graphical Tool for Model-Driven Development Using Components and Services

A Heterogeneous Approach for Developing Applications with FIWARE GEs

Emerging drugs for the treatment of sarcopenia in cirrhosis of the liver

Albumin levels are associated with portal hypertension in patients with porto sinusoidal vascular disorder

THU-261 - Albumin levels are associated with portal hypertension in patients with porto sinusoidal vascular disorder

WED-022 De novo malignancies after liver transplantation: a twenty years long-single center experience

Role of extracellular vesicles in sarcopenia associated to chronic liver diseases

THU-352 - Role of extracellular vesicles in sarcopenia associated to chronic liver diseases

SAT083 - Preliminary results of the effects of beta-hydroxy-beta-methylbutyrate supplementation in patients with liver cirrhosis: a randomized controlled pilot study

Preliminary results of the effects of beta-hydroxy-beta-methylbutyrate supplementation in patients with liver cirrhosis: a randomized controlled pilot study

THU-350 - Platelets from patients with decompensated cirrhosis display pro-inflammatory features

Platelets from patients with decompensated cirrhosis display pro-inflammatory features

The additive value of sarcopenia, myosteatosis and hepatic encephalopathy in the predictivity of model for end-stage liver disease

FRI-398-Impact of sarcopenia and myosteatosis on post-transplant complications and survival

Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis

Suchergebnisse filtern